U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Lung carcinoma

MedGen UID:
195765
Concept ID:
C0684249
Neoplastic Process
Synonyms: Cancer of Lung; Cancer of the Lung; Carcinoma of Lung; carcinoma of lung; Carcinoma of the Lung; carcinoma of the lung; Lung Cancer; Lung Carcinoma; lung carcinoma
 
Gene (location): FASLG (1q24.3)
 
Monarch Initiative: MONDO:0005138

Definition

Lung cancer is the leading cause of cancer deaths in the U.S. and worldwide. The 2 major forms of lung cancer are nonsmall cell lung cancer and small cell lung cancer (see 182280), which account for 85% and 15% of all lung cancers, respectively. Nonsmall cell lung cancer can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. Cigarette smoking causes all types of lung cancer, but it is most strongly linked with small cell lung cancer and squamous cell carcinoma. Adenocarcinoma is the most common type in patients who have never smoked. Nonsmall cell lung cancer is often diagnosed at an advanced stage and has a poor prognosis (summary by Herbst et al., 2008). [from OMIM]

Additional description

From MedlinePlus Genetics
Lung cancer is a disease in which certain cells in the lungs become abnormal and multiply uncontrollably to form a tumor. Lung cancer may not cause signs or symptoms in its early stages. Some people with lung cancer have chest pain, frequent coughing, blood in the mucus, breathing problems, trouble swallowing or speaking, loss of appetite and weight loss, fatigue, or swelling in the face or neck. Additional symptoms can develop if the cancer spreads (metastasizes) into other tissues. Lung cancer occurs most often in adults in their sixties or seventies. Most people who develop lung cancer have a history of long-term tobacco smoking; however, the condition can occur in people who have never smoked.

Lung cancer is generally divided into two types, small cell lung cancer and non-small cell lung cancer, based on the size of the affected cells when viewed under a microscope. Non-small cell lung cancer accounts for 85 percent of lung cancer, while small cell lung cancer accounts for the remaining 15 percent.

Small cell lung cancer grows quickly and in more than half of cases the cancer has spread beyond the lung by the time the condition is diagnosed. Small cell lung cancer often metastasizes, most commonly to the liver, brain, bones, and adrenal glands (small hormone-producing glands located on top of each kidney). After diagnosis, most people with small cell lung cancer survive for about 1 year; less than seven percent survive 5 years.

Non-small cell lung cancer is divided into three main subtypes: adenocarcinoma, squamous cell carcinoma, and large cell lung carcinoma. Adenocarcinoma arises from the cells that line the small air sacs (alveoli) located throughout the lungs. Squamous cell carcinoma arises from squamous cells that line the passages leading from the windpipe (trachea) to the lungs (bronchi). Large cell carcinoma arises from epithelial cells that line the lungs. Large cell carcinoma encompasses non-small cell lung cancers that do not appear to be adenocarcinomas or squamous cell carcinomas. The 5-year survival rate for people with non-small cell lung cancer is usually between 11 and 17 percent; it can be lower or higher depending on the subtype and stage of the cancer.  https://medlineplus.gov/genetics/condition/lung-cancer

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  

Professional guidelines

PubMed

Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NTN, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, Stevens G, Sulman E, van den Bent M, Wallace HJ, Weinberg JS, Zadeh G, Schiff D
J Clin Oncol 2022 Feb 10;40(5):492-516. Epub 2021 Dec 21 doi: 10.1200/JCO.21.02314. PMID: 34932393
Osmani L, Askin F, Gabrielson E, Li QK
Semin Cancer Biol 2018 Oct;52(Pt 1):103-109. Epub 2017 Nov 26 doi: 10.1016/j.semcancer.2017.11.019. PMID: 29183778Free PMC Article
Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA
Mayo Clin Proc 2008 May;83(5):584-94. doi: 10.4065/83.5.584. PMID: 18452692Free PMC Article

Curated

UK NICE guideline NG122, Lung cancer: diagnosis and management

Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)

Suggested Reading

PubMed

Pasche B, Grant SC
JAMA 2014 May 21;311(19):1975-6. doi: 10.1001/jama.2014.3742. PMID: 24846033

Recent clinical studies

Etiology

The Lancet
Lancet 2022 Apr 16;399(10334):1441. doi: 10.1016/S0140-6736(22)00698-5. PMID: 35430006
Lareau S, Slatore C, Smyth R
Am J Respir Crit Care Med 2021 Dec 15;204(12):P21-P22. doi: 10.1164/rccm.20411P21. PMID: 34908517
Cukic V
Med Arch 2017 Jun;71(3):212-214. doi: 10.5455/medarh.2017.71.212-214. PMID: 28974836Free PMC Article
Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, Escriu C, Peters S; ESMO Guidelines Committee
Ann Oncol 2017 Jul 1;28(suppl_4):iv1-iv21. doi: 10.1093/annonc/mdx222. PMID: 28881918
Lin PY, Yu SL, Yang PC
Br J Cancer 2010 Oct 12;103(8):1144-8. Epub 2010 Sep 21 doi: 10.1038/sj.bjc.6605901. PMID: 20859290Free PMC Article

Diagnosis

Lareau S, Slatore C, Smyth R
Am J Respir Crit Care Med 2021 Dec 15;204(12):P21-P22. doi: 10.1164/rccm.20411P21. PMID: 34908517
Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS
Lancet 2021 Aug 7;398(10299):535-554. Epub 2021 Jul 21 doi: 10.1016/S0140-6736(21)00312-3. PMID: 34273294
Suster DI, Mino-Kenudson M
Arch Med Res 2020 Nov;51(8):784-798. Epub 2020 Aug 29 doi: 10.1016/j.arcmed.2020.08.004. PMID: 32873398
Jonna S, Subramaniam DS
Discov Med 2019 Mar;27(148):167-170. PMID: 31095926
Osmani L, Askin F, Gabrielson E, Li QK
Semin Cancer Biol 2018 Oct;52(Pt 1):103-109. Epub 2017 Nov 26 doi: 10.1016/j.semcancer.2017.11.019. PMID: 29183778Free PMC Article

Therapy

Bungaro M, Novello S, Passiglia F
Curr Treat Options Oncol 2022 Dec;23(12):1699-1720. Epub 2022 Nov 17 doi: 10.1007/s11864-022-01033-4. PMID: 36394791
Ma SC, Bai X, Guo XJ, Liu L, Xiao LS, Lin Y, Tan JL, Cai XT, Wen YX, Ma H, Fu QJ, Leng MX, Zhang YP, Long LL, Guo ZQ, Wu DH, Zhou JG, Dong ZY
BMC Med 2022 Apr 12;20(1):120. doi: 10.1186/s12916-022-02315-2. PMID: 35410334Free PMC Article
Majeed U, Manochakian R, Zhao Y, Lou Y
J Hematol Oncol 2021 Jul 8;14(1):108. doi: 10.1186/s13045-021-01121-2. PMID: 34238332Free PMC Article
Baena J, Modrego A, Zeaiter A, Kahatt C, Alfaro V, Jimenez-Aguilar E, Mazarico JM, Paz-Ares L
Future Oncol 2021 Jun;17(18):2279-2289. Epub 2021 Mar 19 doi: 10.2217/fon-2020-1212. PMID: 33736462
Khunger M, Rakshit S, Pasupuleti V, Hernandez AV, Mazzone P, Stevenson J, Pennell NA, Velcheti V
Chest 2017 Aug;152(2):271-281. Epub 2017 May 10 doi: 10.1016/j.chest.2017.04.177. PMID: 28499515

Prognosis

Grønberg BH, Killingberg KT, Fløtten Ø, Brustugun OT, Hornslien K, Madebo T, Langer SW, Schytte T, Nyman J, Risum S, Tsakonas G, Engleson J, Halvorsen TO
Lancet Oncol 2021 Mar;22(3):321-331. doi: 10.1016/S1470-2045(20)30742-7. PMID: 33662285
Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, Mariotto AB, Lowy DR, Feuer EJ
N Engl J Med 2020 Aug 13;383(7):640-649. doi: 10.1056/NEJMoa1916623. PMID: 32786189Free PMC Article
Giaj Levra M, Cotté FE, Corre R, Calvet C, Gaudin AF, Penrod JR, Grumberg V, Jouaneton B, Jolivel R, Assié JB, Chouaïd C
Lung Cancer 2020 Feb;140:99-106. Epub 2019 Dec 31 doi: 10.1016/j.lungcan.2019.12.017. PMID: 31911324
National Lung Screening Trial Research Team
J Thorac Oncol 2019 Oct;14(10):1732-1742. Epub 2019 Jun 28 doi: 10.1016/j.jtho.2019.05.044. PMID: 31260833Free PMC Article
Ginsberg RJ, Rubinstein LV
Ann Thorac Surg 1995 Sep;60(3):615-22; discussion 622-3. doi: 10.1016/0003-4975(95)00537-u. PMID: 7677489

Clinical prediction guides

De Marchi P, Leal LF, Duval da Silva V, da Silva ECA, Cordeiro de Lima VC, Reis RM
J Clin Pathol 2021 Nov;74(11):735-740. Epub 2021 Feb 15 doi: 10.1136/jclinpath-2020-206832. PMID: 33589532
Jain D, Nambirajan A, Borczuk A, Chen G, Minami Y, Moreira AL, Motoi N, Papotti M, Rekhtman N, Russell PA, Savic Prince S, Yatabe Y, Bubendorf L; IASLC Pathology Committee
Cancer Cytopathol 2019 May;127(5):325-339. Epub 2019 May 3 doi: 10.1002/cncy.22137. PMID: 31050216Free PMC Article
Öjlert ÅK, Halvorsen AR, Nebdal D, Lund-Iversen M, Solberg S, Brustugun OT, Lingjaerde OC, Helland Å
Mol Oncol 2019 May;13(5):1166-1179. Epub 2019 Apr 10 doi: 10.1002/1878-0261.12475. PMID: 30854794Free PMC Article
McLaughlin J, Han G, Schalper KA, Carvajal-Hausdorf D, Pelekanou V, Rehman J, Velcheti V, Herbst R, LoRusso P, Rimm DL
JAMA Oncol 2016 Jan;2(1):46-54. doi: 10.1001/jamaoncol.2015.3638. PMID: 26562159Free PMC Article
Sculier JP, Meert AP, Berghmans T
Eur Respir Rev 2014 Mar 1;23(131):69-78. doi: 10.1183/09059180.00009013. PMID: 24591664Free PMC Article

Recent systematic reviews

Dong Y, Xu J, Sun B, Wang J, Wang Z
Mol Diagn Ther 2022 Mar;26(2):203-227. Epub 2022 Mar 10 doi: 10.1007/s40291-021-00568-w. PMID: 35266116Free PMC Article
Deng H, Zhao Y, Cai X, Chen H, Cheng B, Zhong R, Li F, Xiong S, Li J, Liu J, He J, Liang W
Crit Rev Oncol Hematol 2022 Feb;170:103582. Epub 2022 Jan 11 doi: 10.1016/j.critrevonc.2022.103582. PMID: 35031441
Yang M, Shen Y, Tan L, Li W
Chest 2019 Jul;156(1):101-111. Epub 2019 May 22 doi: 10.1016/j.chest.2019.04.115. PMID: 31128115
Sommer MS, Staerkind MEB, Christensen J, Vibe-Petersen J, Larsen KR, Holst Pedersen J, Langberg H
J Rehabil Med 2018 Feb 28;50(3):236-245. doi: 10.2340/16501977-2292. PMID: 29392334
Sánchez de Cos Escuín J
Arch Bronconeumol 2017 Dec;53(12):682-687. Epub 2017 Aug 18 doi: 10.1016/j.arbres.2017.06.016. PMID: 28823733

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Curated

    • NICE, 2022
      UK NICE guideline NG122, Lung cancer: diagnosis and management
    • AHRQ, 2013
      Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...